ASTRAZENECA DRNASTRAZENECA DRNASTRAZENECA DRN

ASTRAZENECA DRN

No trades
See on Supercharts

Key facts today

AstraZeneca experienced a 1.9% loss, contributing to a 1.3% decline in the pharmaceutical and biotech sector, which limited overall gains in the FTSE 100 index.
Analyze the impactAnalyze the impact
Market capitalization
‪1.31 T‬BRL
‪29.65 B‬BRL
‪228.07 B‬BRL
‪1.46 B‬
Beta (1Y)
−0.11

About ASTRAZENECA PLC ORD USD0.25


CEO
Pascal Soriot
Headquarters
Cambridge
Founded
1992
ISIN
BRA1ZNBDR003
FIGI
BBG00XX9GNT2
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy